EQUIMET SPRAY NAS FL 15ML0.05%

EQUIMET 0.05% NASAL SPRAY, DEAL

active ingredients

100 ml of solution contain: Active ingredient: Oxytazoline Hydrochloride 0.05 g A spray corresponds to 0.1 ml solution and contains 0.05 mg of oxytazoline For the full list of excipients see 6.1

Excellent

Benzalconio chloride, Potassium hydrogenphosphate, Hydrogen phosphate disodium anidro, Purified water

Therapeutic indications

Nasal mucosa decongestant (free the nose closed), especially in case of cold

Contraindications

Accerted hypersensitivity to oxytazoline or other product components, prostate hypertrophy, heart disease and severe arterial hypertension. Glaucoma, hyperthyroidism. Do not administer during and in the two weeks following antidepressant medication therapy. The drug is contraindicated in children under the age of 12.

Population

Adults and children over 12 years: A spray for nostril every 6-12 hours, if necessary. Do not exceed 4 days of treatment unless otherwise indicated by your doctor. For use remove the plastic cap, introduce the end of the bottle in the nostril and press with fast and decisive motion, breathing deeply with the nose. Do not exceed the recommended doses.

Conservation

Don't refrigerate

Warnings

In patients with cardiovascular disease, especially in hypertensives, the use of nasal decongestants must however be subjected to the medical examination. Protracted use of vasoconstrictors can alter the normal function of the mucosa of the nose and of the paranasal breasts, also inducing addiction to the drug. Repeating applications for long periods may be harmful. Use carefully in the first months of pregnancy and, for the danger of urinary retention, in the elderly. The use, especially if prolonged, of topical products can give rise to awareness: in this case it is necessary to stop the treatment and establish suitable therapy. In the absence of complete therapeutic response within a few days, consult your doctor; in any case the treatment should not be protracted for over 4 days. Strictly adhere to the recommended doses. It should not be used orally. The product, if accidentally ingested or if used for a long time in excessive doses may cause toxic phenomena. It must be kept away from the reach of children, since accidental ingestion can cause marked sedation. Avoid liquid contact with eyes. Attention for sportsmen: the product contains substances prohibited for doping. A different intake is prohibited, by a posological scheme and by way of administration, from those indicated.

Interactions

Do not administer during and in the two weeks following treatment with antidepressant drugs.

Effects

The product can determine locally phenomena of sensitization and congestion of bounce mucosa. For rapid absorption of oxytazoline through inflamed mucosa, systemic effects can occur, consisting of arterial hypertension, reflex bradycardia, headache, urination disorders. Occasionally, irritation and dryness of the throat and mouth can be observed.

Overdosing

In case of overdose, arterial hypertension, tachycardia, photophobia, intense headache, thoracic oppression and, in children, hypothermia and severe depression of the central nervous system with marked sedation, requiring the adoption of adequate emergency measures. You can observe local irritation and congestion of bounce mucosa. Treatment should only be symptomatic.

Use carefully in the first months of pregnancy and during breastfeeding, after having properly assessed the risk/benefit ratio.

Source: Farmadati